The U.S. Food and Drug Administration (FDA) will allow Sanolla’s VoqX to be used in the clinic, the first stethoscope that can be used to detect infrasounds — acoustic waves that humans cannot hear. The primary care stethoscope — a diagnostic tool clinicians normally use to listen to sounds…
Molecules called stapled peptides blocked the secretion, or release, of mucin proteins from airway cells and lessened mucus buildup in the lungs of mice in a study. According to its researchers, these findings led to the creation of an inhaled aerosol that was tested in the mice and, with further…
ENA Respiratory is developing its first-in-class, broad-spectrum antiviral nasal spray — known as INNA-051 — for populations at risk of developing complications from respiratory viral infections, including COVID-19. Now, the Australian company is teaming up with the COPD Foundation, a nonprofit with a mission to improve the…
Animal and human studies highlight the potential of nomacopan, an investigational inhaled medicine to alleviate severe exacerbations caused by inflammatory lung diseases, such as chronic obstructive pulmonary disease (COPD). Akari Therapeutics, the company developing the therapy, is collaborating with Inhalation Sciences to refine the dosing and pharmacological…
A Chinese remedy called Xuanbai Chengqi decoction, or XBCQ, used to treat chronic obstructive pulmonary disease (COPD), modulated immune cells, improved lung function, and reduced lung inflammation by potentially changing the gut microbiome of mice with the disease, a study suggested. “XBCQ could alleviate COPD exacerbations by reshaping the gut…
A hand-held fan blowing air on the face eased breathlessness in people with chronic obstructive pulmonary disease (COPD) during short periods of low-intensity walking exercise, a small study reports. “Our positive preliminary findings suggest that fan therapy merits further investigation in larger and more methodologically rigorous studies,” the researchers…
Female nurses who worked in operating rooms (ORs) for 15 years or more are up to 69% more likely to develop chronic obstructive pulmonary disease (COPD) than those who never served in an OR, according to a large-scale study from the Boston University School of Public Health (BUSPH). Causing…
Researchers at the Centenary UTS Centre for Inflammation in Australia have been awarded grants to investigate potential therapeutics for respiratory conditions like chronic obstructive pulmonary disease (COPD). One of the awards is a $5-million National Health and Medical Research Council (NHMRC) Synergy Grant that will investigate methods in…
The health-related quality of life of people with chronic obstructive pulmonary disease (COPD) living in Barcelona, Spain, is negatively affected by exposure to air pollution and living farther away from green or blue water-rich spaces, a study suggests. “This study, performed for the first time on a Mediterranean population,…
Glenmark Pharmaceuticals has launched Tiogiva, a tiotropium bromide dry powder inhaler (DPI) for the treatment of chronic obstructive pulmonary disease (COPD), in the U.K. Tiogiva is the bioequivalent generic version of Boehringer Ingelheim’s…
Get regular updates to your inbox.